Lau Darren, Pannu Neesh, James Matthew T, Hemmelgarn Brenda R, Kieser Teresa M, Meyer Steven R, Klarenbach Scott
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
J Thorac Cardiovasc Surg. 2021 Sep;162(3):880-887. doi: 10.1016/j.jtcvs.2020.01.101. Epub 2020 Mar 3.
Acute kidney injury (AKI) is common after cardiac surgery. We quantified the mortality and costs of varying degrees of AKI using a population-based cohort in Alberta, Canada.
A cohort of patients undergoing cardiac surgery from 2004 to 2009 was assembled from linked Alberta administrative databases. AKI was classified by Kidney Disease Improving Global Outcomes stages of severity. Our outcomes were in-hospital mortality, length of stay, and costs; among survivors, we also examined mortality and costs at 365 days. Estimates were adjusted for demographic characteristics, comorbidities, and other covariates.
Ten thousand one hundred seventy participants were included, of whom 9771 patients were discharged to community. Overall in-hospital mortality, costs, and length of stay were 4%, 7 days, and Can $34,000, respectively. Postcardiac surgery, AKI occurred in 25%. Compared with those without AKI, AKI was independently associated with increased in-hospital mortality across severity categories, with the highest risk (adjusted odds ratio, 37.1; 95% confidence interval, 26.3-52.1; P < .001) in patients who required acute dialysis. AKI severity was associated with increased hospital days and costs, with costs ranging from 1.21 for stage 1 AKI (95% confidence interval, 1.17-1.23) to 2.74 for acute dialysis (95% confidence interval, 2.49-3.00) (P < .001) times higher than in patients without AKI, after covariate adjustment. Postdischarge to 365 days, patients with AKI continued to experience increased costs up to 1.35-fold, and patients who required dialysis acutely continued to experience a 2.86-fold increased mortality.
AKI remains an important indicator of mortality and health care costs postcardiac surgery.
急性肾损伤(AKI)在心脏手术后很常见。我们使用加拿大艾伯塔省的一个基于人群的队列,对不同程度AKI的死亡率和成本进行了量化。
从艾伯塔省相关行政数据库中收集了2004年至2009年接受心脏手术的患者队列。AKI根据改善全球肾脏病预后组织(KDIGO)的严重程度分期进行分类。我们的结局指标是住院死亡率、住院时间和成本;在幸存者中,我们还检查了365天时的死亡率和成本。估计值根据人口统计学特征、合并症和其他协变量进行了调整。
共纳入1170名参与者,其中9771名患者出院后回到社区。总体住院死亡率、成本和住院时间分别为4%、7天和34000加元。心脏手术后,25%的患者发生AKI。与未发生AKI的患者相比,AKI在各个严重程度类别中均与住院死亡率增加独立相关,其中需要急性透析的患者风险最高(调整后的比值比为37.1;95%置信区间为26.3 - 52.1;P <.001)。AKI的严重程度与住院天数和成本增加相关,调整协变量后,成本从1期AKI的1.21倍(95%置信区间为1.17 - 1.23)到急性透析的2.74倍(95%置信区间为2.49 - 3.00)(P <.001),高于未发生AKI的患者。出院至365天时,发生AKI的患者成本持续增加高达1.35倍,需要急性透析的患者死亡率持续增加2.86倍。
AKI仍然是心脏手术后死亡率和医疗保健成本的重要指标。